{"Row Number": 353, "Calculator Name": "HAS-BLED Score for Major Bleeding Risk", "Calculator ID": "25", "Category": "risk", "Note ID": "10", "Patient Note": "A 72-year-old man finds himself back at the primary care clinic for his routine visit. His well-documented history of uncontrolled hypertension is a notable element in his case file. However, there is no suggestion of a previous stroke episode. He admits to patronizing alcohol, averaging 9 drinks per week. Also noteworthy in his medical history are his liver and renal conditions. On the one hand, he has had numerous hospital admissions over the years with repeated indications of hepatic impairment due to ALD. His renal function has also been a concern, as demonstrated by an elevated creatinine and reduced glomerular filtration rate. Contrarily, when it comes to bleeding risk, he has never been prescribed any medication known to accelerate bleeding. His coagulation profiles are quite stable, demonstrated by a consistently normal international normalized ratio (INR). These medical intricacies necessitate a comprehensive, focused approach to his healthcare management.", "Question": "What is the patient's HAS-BLED score?", "LLM Answer": "4", "LLM Explanation": "The HAS-BLED score assesses bleeding risk with 1 point for each criterion met:\\n\\n- **H (Hypertension):** Uncontrolled hypertension is present (1 point).\\n- **A (Abnormal Liver Function):** Hepatic impairment due to ALD indicates liver issues (1 point).\\n- **S (Stroke):** No history of stroke (0 points).\\n- **B (Bleeding History):** No prior bleeding episodes or medications that increase bleeding (0 points).\\n- **L (Lab Results):** Elevated creatinine and reduced GFR indicate renal impairment (1 point).\\n- **E (Elderly):** Age 72 (\u226565 years) (1 point).\\n- **D (Drugs):** No antiplatelets or NSAIDs mentioned (0 points).\\n\\nTotal score: 1 + 1 + 0 + 0 + 1 + 1 + 0 = **4**.", "LLM Thinking": " <think> Okay, let's tackle this HAS-BLED score calculation. First, I need to recall what the HAS-BLED score entails. HAS-BLED is a tool used to predict the risk of bleeding in patients, often those on anticoagulants. The components are: H \u2013 Hypertension (controlled or not) A \u2013 Abnormal Liver Function S \u2013 Stroke (previous history) B \u2013 Bleeding history L \u2013 Lab results (elevated INR or creatinine) E \u2013 Elderly (over 65) D \u2013 Drugs (antiplatelets or NSAIDs) Wait, let me make sure I have all the components right. Let me think again. The HAS-BLED score includes the following factors, each scored as 1 point if present: - H: Hypertension (SBP >160 mmHg or DBP >90 mmHg) - A: Abdominal trauma or bleeding (or in this case, maybe liver issues? Wait, no. Let me check again. Oh right, the 'A' stands for Abnormal Liver Function or Cirrhosis) - S: Stroke history - B: Bleeding history - L: Lab: creatinine >177 \u03bcmol/L (2 mg/dL) or INR >3.0 - E: Elderly (age \u226565 years) - D: Drugs (antiplatelets or NSAIDs) Wait, maybe I mixed up some components. Let me confirm the exact criteria. HAS-BLED components: Each component is a yes/no (1 or 0): H: Hypertension (SBP \u2265160 or DBP \u2265100 mmHg) \u2013 some sources might have slightly different cutoffs, but common is SBP>140 or DBP>90? Wait, I need to be precise. Let me recall. The original HAS-BLED criteria for hypertension is systolic BP \u2265160 mmHg or diastolic BP \u226590 mmHg. Wait, maybe I should check. Alternatively, perhaps the exact cutoffs are systolic BP \u2265160 or diastolic BP \u226590. Let me proceed with that. A: Abnormal liver function (e.g., cirrhosis, elevated liver enzymes, or ALD as in the case here?) S: Prior Stroke B: Bleeding history (previous bleeding events) L: Lab: elevated creatinine (indicating renal impairment) or INR >3.0 (but if on warfarin, but here the patient's INR is normal) E: Elderly (age \u226565) D: Concomitant use of drugs that increase bleeding risk (like antiplatelets, NSAIDs, etc.) Now, let's go through the patient's details step by step. Patient is 72, so E (elderly) is yes (1 point). Hypertension is uncontrolled. The note says \"uncontrolled hypertension\". The HAS-BLED hypertension component is about uncontrolled BP. The exact BP numbers might matter, but since it's stated as uncontrolled, we can assume that meets the criteria. So H is 1. Abdominal trauma or bleeding? Wait, the 'A' component is for liver issues. The patient has a history of hepatic impairment due to ALD (alcoholic liver disease). So that's cirrhosis or significant liver disease. So A is 1. S: No previous stroke, so S is 0. B: Bleeding history? The note says \"he has never been prescribed any medication known to accelerate bleeding\" and \"coagulation profiles are quite stable, demonstrated by a consistently normal international normalized ratio (INR)\". So no prior bleeding history? The question is whether the patient has a history of bleeding. The note doesn't mention any prior bleeding episodes, so B is 0. L: Lab results. The patient has elevated creatinine and reduced GFR, so that's renal impairment. The L component includes elevated creatinine (over 2 mg/dL or 177 \u03bcmol/L). Since the creatinine is elevated, that's a yes. However, the INR is normal, so that part isn't contributing. So L is 1. E: Already counted as 1 (age 72). D: Drugs that increase bleeding. The patient drinks alcohol (9 drinks per week). Wait, does alcohol count here? The D component is about antiplatelets (like aspirin) or NSAIDs. The note says he hasn't been on medications that accelerate bleeding. So unless alcohol is considered here, but I think the D component is specifically about the drugs, not alcohol. The question states \"no medication known to accelerate bleeding\", so D would be 0. However, some sources might consider alcohol as a risk factor, but according to the HAS-BLED criteria, D is about antiplatelets or NSAIDs. So D is 0. So adding up the points: H (1) + A (1) + S (0) + B (0) + L (1) + E (1) + D (0) = total 4 points. Wait, let me check again: H: 1 (uncontrolled HTN) A: 1 (hepatic impairment from ALD, which is liver disease) S: 0 B: 0 (no prior bleeding) L: 1 (elevated creatinine) E: 1 (age over 65) D: 0 (no antiplatelets/NSAIDs) Total is 1+1+0+0+1+1+0 = 4. Therefore, the HAS-BLED score is 4. ", "Ground Truth Answer": "5", "Ground Truth Explanation": "The current HAS-BLED score is 0.\nThe patient is 72.0 years old. Because the patient's age is greater than 65 years, we increment the score by 1, making the current score 0 + 1 = 1.\nThe patient has 9 drinks a week. Because the patient has at least 8 alcoholic drinks a week, we increment the score by 1, making the current score 1 + 1 = 2.\nThe issue, hypertension, is reported to be present for the patient note and so we increase the score by 1, making the current score 2 + 1 = 3.\nThe issue, liver disease, is reported to be present for the patient note and so we increase the score by 1, making the current score 3 + 1 = 4.\nThe issue, renal disease, is reported to be present for the patient note and so we increase the score by 1, making the current score 4 + 1 = 5.\nThe issue, stroke history, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nThe issue, prior bleeding, is missing from the patient note and so we assume it to be absent and so we do not change the score, keeping the current score at 5.\nThe issue, labile inr, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nThe issue, medications for bleeding, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nHence, the patient's HAS-BLED score is 5.", "Result": "Incorrect"}
{"Row Number": 561, "Calculator Name": "Framingham Risk Score for Hard Coronary Heart Disease", "Calculator ID": "46", "Category": "lab", "Note ID": "pmc-4429202-1", "Patient Note": "A 50-year-old male presented to the emergency department with a three-day history of progressive retrosternal chest pain. His medical history was significant only for acute diverticulitis one year prior to current presentation and a 3-pack year smoking history. He had no history of diabetes, hypertension, or dyslipidemia. He denied personal or family history of cardiovascular diseases, hypercoagulable states, or bleeding disorders. A review of systems was negative for headache, visual disturbances, pruritus, easy bruising, or erythromelalgia.\nOn presentation, the patient's blood pressure was 131/83 mm Hg and heart rate was 84 beats/minute. He was in moderate distress due to pain. Auscultation of the lungs revealed clear breath sounds. Cardiac exam was unremarkable. No hepatosplenomegaly was detected on palpation. There was no erythema or rash on skin exam.\nThe patient's initial CBC revealed a hemoglobin of 14.6 g/dL, hematocrit 43.9%, WBC count 13,100/mm3, and platelet count 1,026,000/mm3. During his previous emergency department visit for acute diverticulitis, his platelet count was 976,000/mm3. This was felt to be reactive due to acute inflammation, and he was discharged on a course of oral antibiotics. He had no subsequent outpatient follow-up.\nAn electrocardiogram showed a normal sinus rhythm with T wave inversions in leads III and aVF (). His initial troponin I was 0.15 ng/mL. A repeat level 6 hours later increased to 2.83 ng/mL, suggesting cardiac ischemia. His LDL was 107 mg/dL, HDL 43 mg/dL, and triglycerides 98 mg/dL. His electrolytes, BUN and creatinine, and liver enzymes were within normal limits.\nThe patient was transferred to the coronary care unit with a diagnosis of NSTEMI. A cardiac catheterization revealed a thrombus in the right coronary artery (RCA) with a 60% stenosis and a TIMI Grade II flow (). No percutaneous coronary intervention (PCI) was performed due to a perceived high risk of complications, specifically distal embolization, given the high platelet count. The patient was treated with aspirin 81 mg daily, prasugrel 10 mg daily, enoxaparin 1 mg/kg every 12 hours, and hydroxyurea 1,000 mg every 12 hours. Four days later, a repeat cardiac catheterization showed normal coronaries with dissolution of the previously found RCA thrombus and no underlying atherosclerotic plaques ().\nA peripheral blood smear was significant for marked thrombocytosis without an increase in immature myeloid elements. Molecular studies were negative for JAK2 mutations in V617F and exon 12 and positive for a CALR mutation type 1 (del52). Testing for BCR/ABL translocations was negative. Hence, a diagnosis of ET was made on the basis of the clinical presentation, consistently high platelet count, and presence of a clonal marker.\nThe patient was discharged home in stable condition on hydroxyurea and low-dose aspirin. His platelet count on discharge was 821,000/mm3. Two months later, his platelet count normalized to 320,000/mm3. He continued to do well with no further thrombotic or hemorrhagic complications. A bone marrow biopsy then was hypocellular and revealed no fibrosis, dysplastic changes, or increase in blasts. Fluorescence in situ hybridization panel for myelodysplastic syndrome was also negative.", "Question": "What is the patient's Framingham Risk Score?", "LLM Answer": "0.05", "LLM Explanation": "The Framingham Risk Score estimates 10-year cardiovascular risk using age, gender, smoking status, total cholesterol, HDL, systolic BP, and hypertension treatment. The patient is a 50-year-old male with a 3-pack year smoking history (assumed current smoker), BP 131/83 (untreated), LDL 107 mg/dL, HDL 43 mg/dL, and triglycerides 98 mg/dL. Total cholesterol is calculated as LDL + HDL + (TG/5) \u2248 170 mg/dL. Framingham points: Age 50 (3), Total Chol 170 (3), HDL 43 (2), SBP 131 untreated (3), smoking (2). Total points = 13, corresponding to a 5% 10-year risk.", "LLM Thinking": " <think> Okay, let's tackle this question. The user is asking for the patient's Framingham Risk Score. First, I need to recall what the Framingham Risk Score (FRS) is. From what I remember, the FRS is a tool used to estimate the 10-year risk of developing cardiovascular disease, specifically coronary heart disease. It's based on several risk factors like age, gender, smoking status, blood pressure, cholesterol levels, diabetes, and possibly other factors. Looking at the patient note provided, let me extract the relevant information. The patient is a 50-year-old male. His blood pressure on presentation was 131/83 mmHg. He has a 3-pack year smoking history, but I need to check if he's a current smoker. The note says \"3-pack year smoking history,\" but it doesn't explicitly state if he's still smoking now. Hmm, that's a bit ambiguous. The Framingham score requires current smoking status, so if he's a current smoker, that's a point. If he quit, then maybe not. Since the note doesn't mention quitting, maybe we have to assume he's still smoking? Or maybe the 3-pack years is past? Wait, the problem might consider pack-years as cumulative, but for FRS, current smoking is needed. Since the note doesn't say he quit, perhaps we have to assume he's a current smoker. But I'm not sure. Let me note that as a possible issue. Next, cholesterol levels. The LDL is 107 mg/dL, HDL 43, triglycerides 98. Wait, the Framingham score uses total cholesterol and HDL, not LDL. Oh right, the original Framingham uses total cholesterol, but there are updated versions. Wait, maybe I need to check which version they're referring to. The original Framingham uses age, sex, smoking, total cholesterol, HDL, systolic BP, and treatment for hypertension. Alternatively, the Reynolds Risk Score includes CRP and family history, but the question specifies Framingham. Let me confirm the variables again. The standard Framingham Risk Score (10-year) for men includes age, total cholesterol, HDL, systolic BP, treatment for hypertension, and smoking. Since the patient's LDL is given, but total cholesterol isn't, that's a problem. Wait, the note provides LDL, HDL, and triglycerides. To get total cholesterol, the formula is approximately LDL + HDL + (Triglycerides / 5). Let me calculate that. LDL is 107, HDL 43, triglycerides 98. So 107 + 43 = 150, plus 98/5 is ~19.6. Total would be around 150 + 19.6 = 169.6 mg/dL. So approximately 170 mg/dL total cholesterol. His systolic BP is 131. He's not on any BP meds because the history says no hypertension. So treatment for hypertension is no. Smoking: as before, the 3-pack year history. Since the note doesn't say he quit, maybe he's a current smoker. But the problem is, the Framingham score requires current smoking status. If he's a current smoker, that's a yes. If he quit, then no. Since the note says \"3-pack year smoking history\" but doesn't mention quitting, perhaps we have to assume he's a current smoker. Alternatively, maybe the 3-pack years is past, but that's unclear. This is a potential ambiguity. Let's proceed with current smoker unless stated otherwise, but note that. Now, let's list all the variables: - Age: 50 - Gender: Male - Total Cholesterol: ~170 mg/dL (calculated) - HDL: 43 mg/dL - Systolic BP: 131 mmHg - Treated for hypertension: No (since no history of hypertension and BP is 131/83, which is elevated but not into hypertension range? Wait, 131/83 is stage 1 hypertension (systolic 130-139 or diastolic 80-89). But the Framingham score considers treatment for hypertension. Since the patient isn't on meds, treatment is no. So even if BP is elevated, if not treated, it's counted as untreated. So the BP variable would be the systolic value, and whether on treatment. So here, systolic is 131, and treatment is no. Smoking: current smoker (assuming yes, since no mention of quitting). Now, applying the Framingham points. Let me recall the scoring tables. Since I can't look them up, I need to remember the points. Alternatively, maybe I can calculate using the formula. The original Framingham equation for men is: 10-year risk = e^(b0 + b1*age + b2*cholesterol + b3*HDL + b4*smoking + b5*BP + b6*treatment) / (1 + e^(...)) But perhaps it's easier to use the points system. Let me think of the points table. Alternatively, maybe I can use an online calculator's approach. Let me try to reconstruct the points. Wait, perhaps the variables are as follows: For men: - Age (years): 50 \u2192 let's see, in the Framingham tables, age categories are in 5-year increments. For 50, the points would be, say, 3 points (but need exact values). Wait, maybe I should recall the points for each variable. Let me try to remember the points for each component. Alternatively, perhaps I can use the following approach: The Framingham Risk Score for men uses the following variables and coefficients in a logistic regression model: The formula is: Risk = 1 / (1 + e^-(a + b1*age + b2*cholesterol + b3*HDL + b4*smoking + b5*SBP + b6*htn_treatment)) But without exact coefficients, this is hard. Alternatively, perhaps I can use the points tables from the Framingham study. Looking up in my mind, the points for each variable: Age: 50 \u2192 let's say 3 points (for example, 45-49 is 2, 50-54 is 3, etc.) Total Cholesterol: 170 mg/dL. The categories are like <160, 160-199, etc. 160-199 might be 3 points. HDL: 43 mg/dL. HDL categories: <35 is 3 points, 35-44 is 2, 45-54 is 1, >55 is 0. So 43 would be 2 points. Systolic BP: 131. The categories are in 10 mmHg increments. 130-139 would be in the 130-139 category. If untreated, the points would be higher. For example, 130-139 untreated: maybe 3 points. Smoking: current smoker \u2192 2 points. Hypertension treatment: no \u2192 0 points. Adding these up: Let's see: Age 50 \u2192 3 Total Chol 170 \u2192 3 (assuming 160-199 is 3) HDL 43 \u2192 2 SBP 131 untreated \u2192 3 (since 130-139 untreated) Smoking \u2192 2 Total points: 3+3+2+3+2 = 13. Then, the 10-year risk would be looked up from a table. For a total of 13 points, maybe around 5-6% risk? But I'm not sure. Alternatively, maybe the points are different. Alternatively, perhaps I should use the actual Framingham points table. Let me try to recall: For men: Age (years): 40-44: 0 45-49: 2 50-54: 3 55-59: 4 60-64: 5 65-69: 6 70-74: 7 So 50 is 3 points. Total Cholesterol (mg/dL): <160: 0 160-199: 3 200-239: 5 240-279: 7 >=280: 9 So 170 is 3. HDL (mg/dL): <35: 3 35-44: 2 45-54: 1 >=55: 0 43 is 2. Systolic BP (mmHg): Untreated: <120: 0 120-129: 1 130-139: 3 140-159: 5 >=160: 7 Treated: <120: 1 120-139: 3 >=140: 5 Here, SBP is 131, untreated \u2192 3 points. Smoking: Current smoker: 2 Non-smoker: 0 So 2 points. Hypertension treatment: no \u2192 0. Total points: 3 (age) +3 (cholesterol) +2 (HDL) +3 (SBP) +2 (smoking) = 13 points. Looking up the Framingham table, 13 points correspond to a 10-year risk of approximately 5-6%? Wait, let me think. The Framingham points to risk mapping: For men, 13 points would be in the 5-6% range. For example, 12 points is 4%, 13 is 5%, 14 is 6%, etc. So maybe the answer is around 5-6%? But the question is asking for the Framingham Risk Score, which is the numerical value, not the percentage. Wait, actually, the Framingham Risk Score is the points, but sometimes people refer to the percentage as the score. Wait, the question says \"Framingham Risk Score\"\u2014the points or the percentage? Hmm, the Framingham Risk Score (FRS) is the 10-year risk percentage. The points are intermediate. So if the total points are 13, then the corresponding risk is the percentage. Let me see if I can recall the exact mapping. Looking up in my mind, the Framingham points to risk for men: Points: 0-4 \u2192 <1% 5 \u2192 1% 6 \u2192 2% 7 \u2192 3% 8 \u2192 4% 9 \u2192 5% 10 \u2192 6% 11 \u2192 7% 12 \u2192 8% 13 \u2192 9% Wait, maybe my previous thought was off. Alternatively, perhaps the points are different. Alternatively, maybe I should use an example. Let me think of another way. Alternatively, perhaps the Framingham equation uses a formula. The original Framingham equation for men is: The 10-year risk is calculated using the formula: Risk = (e^(b0 + b1*age + b2*cholesterol + b3*HDL + b4*smoking + b5*SBP + b6*htn_treatment)) / (1 + e^(...)) But without the exact coefficients, this is hard. Alternatively, maybe I can use an online calculator's approach. Let me try to approximate. Alternatively, perhaps the user expects the points, but the question says \"score\", which is the percentage. Since the points are 13, and if 13 points correspond to ~5-6%, but I'm not sure. Alternatively, maybe I made a mistake in the calculation. Wait, let me recalculate the total points again: Age 50 \u2192 3 Total Cholesterol 170 \u2192 3 (since 160-199 is 3) HDL 43 \u2192 2 (35-44 is 2) SBP 131 untreated \u2192 3 (130-139 untreated is 3) Smoking \u2192 2 (current) Total: 3+3+2+3+2 = 13 points. Looking up a Framingham table, for men, 13 points would be approximately 5-6% risk. Let me see an example table: From the Framingham website or standard tables: Men's 10-year risk: Points: 13 \u2192 5% (maybe 5% is 12 points, 13 is 6%?) Alternatively, here's a possible table: Points | Risk (%) 12 \u2192 4% 13 \u2192 5% 14 \u2192 6% 15 \u2192 7% 16 \u2192 8% 17 \u2192 9% 18 \u2192 10% So 13 points would be 5% risk. Therefore, the Framingham Risk Score (as the percentage) would be 5%. Wait, but I need to be precise. Alternatively, maybe the exact calculation is needed. Let me think of another approach. Alternatively, perhaps the Framingham score requires total cholesterol, but since we had to calculate it from LDL, HDL, and triglycerides, maybe that's an issue. The given LDL is 107, HDL 43, triglycerides 98. The formula for total cholesterol is LDL + HDL + (TG/5). So 107 +43 = 150, plus 98/5 is ~19.6, totaling ~169.6, so ~170 mg/dL. That seems correct. Another possible mistake: the systolic BP is 131. The Framingham considers whether the patient is treated for hypertension. Since the patient has no history of hypertension and isn't on meds, even though BP is 131, which is elevated (stage 1 hypertension), but untreated. So the BP category is 130-139, untreated, which gives 3 points. So total points are indeed 13. So the 10-year risk is 5%? Let me check another source in my mind. For example, in some tables, 13 points for men would be 5% risk. So the answer would be 5%. Alternatively, maybe the Framingham score here is different. Wait, the patient has a history of diverticulitis and ET (essential thrombocythemia), but those aren't part of the Framingham calculation. The FRS is purely based on the standard risk factors. Therefore, the answer should be 5% or 6%? Hmm. Alternatively, perhaps I made a mistake in the HDL points. Let me check again: HDL of 43 is in the 35-44 range, which is 2 points. Correct. Smoking: current smoker (assuming yes) gives 2 points. Correct. Age 50: 3 points. Correct. Total Cholesterol 170: 3 points. Correct. SBP 131 untreated: 3 points. Correct. Total 13. So 5%? Let me see another way. Suppose the points are 13, then according to the Framingham table for men, 13 points is 5% risk. So the answer is 5%. Alternatively, maybe the Framingham score is presented as points, but the question asks for the score, which is the percentage. So the answer is 5%. Wait, but I need to make sure. Let me think of another example. For a 50-year-old male with similar factors: Suppose another person with same age, same cholesterol, etc. Let me see an example online (from memory). For example, a 50-year-old male with total cholesterol 170, HDL 43, BP 131, smoker, no treatment for HTN. The points would be 3+3+2+3+2=13. The 10-year risk is 5%. Therefore, the answer should be 5%. But wait, the patient has a history of ET (essential thrombocythemia) and had an NSTEMI. However, the Framingham score doesn't account for that. The question is specifically asking for the Framingham Risk Score, which is based on the standard risk factors listed. So those other factors are irrelevant here. Therefore, the Framingham Risk Score (10-year risk) is 5%. ", "Ground Truth Answer": "0", "Ground Truth Explanation": "The patient's gender is Male.\nFor males, the formula for computing the framingham risk score is 52.00961 * ln(age) + 20.014077 * ln(total_cholestrol) + -0.905964 * ln(hdl_cholestrol) + 1.305784 * ln(sys_bp) + 0.241549 * bp_medicine + 12.096316 * smoker + -4.605038 * ln(age) * ln(total_cholestrol) + -2.84367 * ln(age_smoke) * smoker + -2.93323 * ln(age) * ln(age) -  172.300168, where 'bp_medicine' is a binary variable for whether a patient's blood pressure is being treated with medicine, total cholestrol and hdl cholestrol are in mg/dL, and 'smoker' is whether the patient is a smoker or not.\nFrom this, we use the risk score to get likelihood for a patient getting myocardial infraction (MI) or dying in the next 10 years: 1 - 0.9402^exp(risk_score), where risk_score is the value from the formula above.\nThe patient is 50 years old. The patient is a smoker, making the smoking variable equal to 1.\nThe patient's systolic blood pressure is 131.0 mm Hg.\nThe patient has been specified to not take medication for treating their blood pressure, making the bp_medicine variable equal to 0.\nThe concentration of total cholestrol is 107.0 mg/dL. We need to convert the concentration to mmol/L. Let's first convert the mass of total cholestrol from mg to mmol. The mass of total cholestrol is 107.0 mg. To convert 107.0 mg of total cholestrol to g, multiply by the conversion factor 0.001, giving us 107.0 mg total cholestrol * 0.001 g/mg = 0.107 g total cholestrol. To convert from grams of total cholestrol to moles, divide by the molar mass 386.65 g/mol, which will give 0.107 g/(386.65 g total cholestrol/mol) = 0.000277 mol total cholestrol. To convert 0.000277 mol of total cholestrol to mmol, multiply by the conversion factor 1000.0, giving us 0.000277 mol total cholestrol * 1000.0 mmol/mol = 0.277 mmol total cholestrol. The current volume unit is dL and the target volume unit is L. The conversion factor is 0.1 L for every unit of dL. Our next step will be to divide the mass by the volume conversion factor of 0.1 to get the final concentration in terms of mmol/L. This will result to 0.277 mmol total cholestrol/0.1 L = 2.77 mmol total cholestrol/L. The concentration value of 107.0 mg total cholestrol/dL converts to 2.77 mmol total cholestrol/L. \nThe concentration of hdl cholestrol is 43.0 mg/dL. We need to convert the concentration to mmol/L. Let's first convert the mass of hdl cholestrol from mg to mmol. The mass of hdl cholestrol is 43.0 mg. To convert 43.0 mg of hdl cholestrol to g, multiply by the conversion factor 0.001, giving us 43.0 mg hdl cholestrol * 0.001 g/mg = 0.043 g hdl cholestrol. To convert from grams of hdl cholestrol to moles, divide by the molar mass 386.65 g/mol, which will give 0.043 g/(386.65 g hdl cholestrol/mol) = 0.000111 mol hdl cholestrol. To convert 0.000111 mol of hdl cholestrol to mmol, multiply by the conversion factor 1000.0, giving us 0.000111 mol hdl cholestrol * 1000.0 mmol/mol = 0.111 mmol hdl cholestrol. The current volume unit is dL and the target volume unit is L. The conversion factor is 0.1 L for every unit of dL. Our next step will be to divide the mass by the volume conversion factor of 0.1 to get the final concentration in terms of mmol/L. This will result to 0.111 mmol hdl cholestrol/0.1 L = 1.11 mmol hdl cholestrol/L. The concentration value of 43.0 mg hdl cholestrol/dL converts to 1.11 mmol hdl cholestrol/L. \nPlugging in these values will give us the risk score:  52.00961 * ln(50) + 20.014077 * ln(2.77) + -0.905964 * ln(1.11) + 1.305784 * ln(131.0) + 0.241549 * 0  + 12.096316 * 1 + -4.605038 * ln(50) * ln(2.77) + -2.84367 * ln(50) * 1 + -2.93323 * ln(50) * ln(50) -  172.300168 = -4.4.\nPlugging this into the MI risk equation gives us 1 - 0.9402^exp(-4.4) = 0.0 %.\nThe patient's percentage of getting MI or dying is 0.0 %.", "Result": "Incorrect"}
{"Row Number": 875, "Calculator Name": "APACHE II Score", "Calculator ID": "28", "Category": "risk", "Note ID": "8", "Patient Note": "A 60-year-old male with a history of liver failure and immunocompromise presents to the emergency department with acute symptoms of lethargy and decreased appetite. Physical examination reveals tachycardia to 95 beats per minute, respiratory rate of 19 breaths per minute, blood pressure registering at 135/75 mm Hg and a baseline temperature of 37.2\u00b0C. Neurological assessment demonstrates mild confusion, corresponding to a Glasgow Coma Score of 14. Blood tests reveal elevated creatinine levels at 3.8 mg/dL. Metabolic panel showed sodium at 138 and potassium at 4.5 mEq/L. The white blood cell count was 12,000 per \u00b5L, triggering concern for a possible infection. Hematocrit was just within normal range at 43 %. The patient had an arterial blood gas pH of 7.32 and a A-a-gradient of 364, with a supplementary FiO\u2082 of 55 %. This patient's acute renal failure symptomatology, alongside the history of severe organ failure and immunocompromised, mandate rigorous monitoring and urgent medical intervention.", "Question": "What is the patient's APACHE II score?", "LLM Answer": "name 'N' is not defined", "LLM Explanation": "name 'N' is not defined", "LLM Thinking": "No Thoughts", "Ground Truth Answer": "36", "Ground Truth Explanation": "The patient's current APACHE II score is 0 points.\nThe patient is 60.0 years old. The patient is reported to have an organ failure of immunocompromise with a surgery type being classified as Nonoperative. Because the patient's age is between 55 and 64, 3 points are added to the total, making the current total, 0 + 3 = 3.\nThe patient's FiO2 percentage is 55.0 %. Because the patent's FiO2 percentrage is greater than 50%, we need to examine the A-a-gradient to compute the APACHE II score. The patient's A-a-gradient is 364. Because the patient's A-a gradient is between 350 and 500, we add 3 points to the total, making the current total 6.\nThe patient's temperature is 37.2 degrees fahrenheit. To convert to degrees celsius, apply the formula 5/9 * [temperature (degrees fahrenheit) - 32]. This means that the patient's temperature is 5/9 * 5.200000000000003 = 2.889 degrees celsius. \nBecause the patient's temperature is below 30 degrees Celsius, 4 points are added to the score, making the current total, 6 + 4 = 10.\nThe mean average pressure is computed by the formula 2/3 * (diastolic blood pressure) + 1/3 * (systolic blood pressure). Plugging in the values, we get 2/3 * 75.0 mm Hg + 1/3 * 135.0 mm Hg = 95.0 mm Hg.\nHence, the patient's mean arterial pressure is 95.0 mm Hg.\nBecause the patient's Mean Arterial Pressure is between 70 and 109 mmHg, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's heart rate is between 70 and 109 beats per minute, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's respiratory rate is between 12 and 24 breaths per minute, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's sodium level is between 130 and 149 mmol/L, 0 points are added to the patient's score, keeping the total at 10. Because the patient's potassium level is between 3.5 and 5.4 mmol/L, 0 points are added to the patient's score, keeping the total at 10. Because the patient has acute renal failure and a creatinine level above 3.5, 8 points are added to the score, making the current total 10 + 8 = 18.\nBecause the patient's hemocratit is between 30% and 45%, 0 points are added to the patient's score, keeping the total at 18. Because the patient's white blood cell count is above 40 x10^9/L, 4 points are added to the score, making the current total 18 + 4 = 22.\nThe patient's Glasgow Coma Score is 14.0, and so we add 14.0 points to the total making the current total 14.0 + 22 = 36.0. Hence, the patient's APACHE II score is 36.0.", "Result": "Incorrect"}
{"Row Number": 981, "Calculator Name": "Target weight", "Calculator ID": "61", "Category": "physical", "Note ID": "14", "Patient Note": "Patient has a height of 77 in and their target BMI is 19.7 kg/m^2.", "Question": "Based on the patient's height and target BMI, what is the patient's target weight in kg?", "LLM Answer": "75.4", "LLM Explanation": "First, convert the patient's height from inches to meters. 77 inches multiplied by 0.0254 meters per inch equals 1.9558 meters. Next, calculate the square of the height in meters: (1.9558 m)^2 \u2248 3.82515 m\u00b2. Using the BMI formula (weight = BMI \u00d7 height\u00b2), multiply the target BMI (19.7 kg/m\u00b2) by the squared height: 19.7 \u00d7 3.82515 \u2248 75.355 kg. Rounding to one decimal place, the target weight is 75.4 kg.", "LLM Thinking": " <think> Okay, let's see. The patient's height is 77 inches, and their target BMI is 19.7 kg/m\u00b2. I need to find their target weight in kilograms. Hmm, right, BMI is calculated as weight divided by height squared, but the formula uses meters. Wait, the height here is in inches, so I need to convert that to meters first. First, I remember that 1 inch is 0.0254 meters. So to convert 77 inches to meters, I multiply 77 by 0.0254. Let me do that calculation. 77 times 0.0254... let's see, 70*0.0254 is 1.778, and 7*0.0254 is 0.1778, so adding those together gives 1.778 + 0.1778 = 1.9558 meters. So the height in meters is approximately 1.9558 m. Now, the BMI formula is BMI = weight / (height in meters)^2. We need to solve for weight. So rearranging the formula, weight = BMI * (height)^2. Plugging in the numbers: 19.7 multiplied by (1.9558)^2. Let me calculate the square of 1.9558 first. Calculating 1.9558 squared: 1.9558 * 1.9558. Let me approximate this. 2 squared is 4, but since it's a bit less than 2, maybe around 3.825? Wait, let me do it more accurately. 1.9558 * 1.9558. Let's compute 1.95 * 1.95 first, which is 3.8025. Then the extra 0.0058 parts. Hmm, maybe better to do (2 - 0.0442)^2. Wait, maybe just multiply it out step by step. Alternatively, 1.9558 * 1.9558: First, 1.9558 * 1 = 1.9558, 1.9558 * 0.9 = 1.76022, 1.9558 * 0.05 = 0.09779, 1.9558 * 0.0058 = approximately 0.01134. Adding those up? Wait, maybe that's complicating. Alternatively, using calculator steps: 1.9558 * 1.9558: Multiply 19558 by 19558, then adjust the decimal. But that's too tedious. Alternatively, approximate: 1.9558 squared is approximately (2 - 0.0442)^2 = 4 - 2*2*0.0442 + (0.0442)^2 \u2248 4 - 0.1768 + 0.00195 \u2248 3.82515. Wait, maybe that's a better way. Let me check: Wait, (a - b)^2 = a\u00b2 - 2ab + b\u00b2. So if a=2, b=0.0442, then: (2 - 0.0442)^2 = 4 - 2*(2)*(0.0442) + (0.0442)^2 = 4 - 0.1768 + 0.00195 \u2248 4 - 0.1768 is 3.8232, plus 0.00195 gives 3.82515. So approximately 3.825 m\u00b2. So then, the weight would be 19.7 * 3.825. Let me calculate that. 20 * 3.825 is 76.5, so subtract 0.3 * 3.825 (since 19.7 is 20 - 0.3). 0.3 * 3.825 = 1.1475. So 76.5 - 1.1475 = 75.3525 kg. Wait, but maybe my approximation of the squared height was off. Let me recalculate the height squared more accurately. Let's do 1.9558 * 1.9558 precisely: 1.9558 * 1.9558: First, multiply 1.9558 by 1.9558: Let me write it as (1.95 + 0.0058) * (1.95 + 0.0058) = (1.95)^2 + 2*1.95*0.0058 + (0.0058)^2. 1.95 squared is 3.8025. 2*1.95*0.0058 = 3.9 * 0.0058 = 0.02262. 0.0058 squared is ~0.00003364. Adding all together: 3.8025 + 0.02262 = 3.82512 + 0.00003364 \u2248 3.82515. So that's accurate. So 3.82515 m\u00b2. So 19.7 * 3.82515. Let's compute that: 19.7 * 3.82515. Breaking it down: 20 * 3.82515 = 76.503 Subtract 0.3 * 3.82515 = 1.147545 So 76.503 - 1.147545 = 75.355455 kg. So approximately 75.36 kg. Rounding to two decimal places, maybe 75.36 kg. But perhaps the question expects rounding to one decimal or a whole number? Let me check the problem again. The target BMI is given as 19.7, which is one decimal. The height is 77 inches, exact. So maybe the answer should be to one decimal place. So 75.4 kg? Wait, 75.355 is approximately 75.4 when rounded to one decimal. Alternatively, maybe they want it more precise. Let me see. Alternatively, perhaps I should use more precise steps. Let me recalculate the height conversion again to ensure no error there. 77 inches * 0.0254 m/inch. 77 * 0.0254. Let's compute 70*0.0254 = 1.778, 7*0.0254=0.1778. Adding those gives 1.778 +0.1778 = 1.9558 m. That's correct. So the calculation steps are correct. So the target weight is approximately 75.36 kg. Depending on rounding, maybe 75.4 kg. But perhaps the problem expects an exact calculation without rounding intermediate steps. Let me try using the exact value of height squared. Alternatively, maybe I should use the formula directly with inches, but converted properly. Wait, the standard BMI formula uses meters, so the conversion must be done first. Alternatively, there's a formula that uses inches and pounds, but since the answer needs to be in kg, better to stick with meters. Alternatively, let me recalculate the multiplication precisely: 19.7 * 3.82515: First, 19 * 3.82515 =? 19 * 3 = 57, 19 * 0.82515 = 15.67785. So total 57 +15.67785 = 72.67785. Then 0.7 * 3.82515 = 2.677605. Adding those together: 72.67785 + 2.677605 = 75.355455 kg. So exactly 75.355455 kg. Rounding to two decimal places would be 75.36 kg, or to one decimal 75.4 kg. Since the given BMI is to one decimal, maybe the answer should be one decimal. So 75.4 kg. Alternatively, perhaps the question expects rounding to the nearest whole number. Let me see if there's a standard practice here. Typically, weight can be given to one decimal place. So I'll go with 75.4 kg. Wait, but let me check again. The exact value is approximately 75.355, so 75.4 when rounded to one decimal. Alternatively, maybe the problem expects more precise. Hmm. Alternatively, perhaps I should present it as 75.4 kg. Alternatively, maybe the question expects an exact calculation without rounding the height conversion. Let me check the height conversion again. 77 inches * 0.0254 m/inch is exactly 77 * 0.0254. Let me compute that precisely. 77 * 0.0254: 0.0254 * 70 = 1.778 0.0254 *7 = 0.1778 Total 1.778 +0.1778 = 1.9558 m exactly. So that's precise. So the squared is 1.9558^2 = 3.82515 m\u00b2. So 19.7 * 3.82515 = 75.355455 kg. So the precise answer is approximately 75.36 kg. Depending on the required precision, but since the given BMI is 19.7 (one decimal), perhaps the answer should be to one decimal place. So 75.4 kg. Alternatively, maybe two decimals. The question doesn't specify, but in medical contexts, sometimes one decimal is common. Let me see. Alternatively, perhaps the answer is 75.4 kg. Alternatively, maybe the problem expects rounding to the nearest whole number. Let me see. 75.355 is closer to 75.4 than 75.3, so 75.4. So I think the answer is 75.4 kg. Wait, but let me check once more. Let me do the calculation again step by step to ensure no arithmetic errors. Height in meters: 77 * 0.0254 = 1.9558 m. Height squared: (1.9558)^2 = 3.82515 m\u00b2. Multiply by BMI: 19.7 * 3.82515. Let me compute 19.7 * 3.82515: First, 20 * 3.82515 = 76.503 Subtract 0.3 * 3.82515 = 1.147545 76.503 - 1.147545 = 75.355455. Yes, that's correct. So 75.355455 kg. So if rounding to one decimal, it's 75.4 kg. If two decimals, 75.36. Since the question doesn't specify, but the given BMI has one decimal, I think one decimal is appropriate. So the answer is 75.4 kg. ", "Ground Truth Answer": "75.371", "Ground Truth Explanation": "The patient's target bmi is 19.7 kg/m^2. The patient's height is 77 in, which is 77 in * 0.0254 m / in = 1.956 m. From this, the patient's target weight is 19.7 kg/m^2 * 1.956 m * 1.956 m = 75.371 kg. ", "Result": "Correct"}
{"Row Number": 32, "Calculator Name": "CKD-EPI Equations for Glomerular Filtration Rate", "Calculator ID": "3", "Category": "lab", "Note ID": "pmc-7983145-1", "Patient Note": "A 38-year-old female was admitted to the emergency ward with altered sensorium and anuria. She had off and on constitutional symptoms of disease such as general malaise, myalgia, polyarthralgia (mainly involved knee, elbow, and ankle joints), anorexia, weight loss, headache, and pyrexia from the last 4 years. She also had a history of recurrent blood-stained nasal discharge, epistaxis, nasal crusting, nasal ulceration, cough, breathlessness, stridor, and wheeze from the last 3 years. She had a history of pedal edema 3 months back. She also complained of diminution of vision with redness of eyes from 3 months. The patient had a history of ulcers on lips and tongue from the past 4 days and decreased frequency of urination from 3 days. There is no history of hematuria, hemoptysis, or cardiovascular manifestations. On examination, her vitals were deranged; she had tachycardia (120/bpm) and hypotension (100/60 mm of Hg). She also had pallor and bilateral pedal edema. There was high suspicion of GPA with acute renal failure or rapidly progressive glomerulonephritis associated with systemic small-vessel vasculitis. Keeping these two main diagnoses in mind, the investigations were ordered accordingly.\nIt is based on a combination of clinical manifestations of systemic disease, positive ANCA serology, and histological evidence of necrotizing vasculitis, necrotizing glomerulonephritis, or granulomatous inflammation of affected organs such as skin, lung, or kidney.\nA trucut biopsy was taken from the right kidney of the patient and detailed analysis was done. On light microscopy, there was focal segmental necrotizing glomerulonephritis involving more than 60% glomeruli associated with extracapillary proliferation with pauci-immune crescent formation. Electron microscopic examination showed fibrinoid deposition in the glomerular basement membrane. In biochemistry, serum sodium (159 mmol/L) and serum potassium levels (17 mmol/L) were deranged. In kidney panel, serum urea (155.8 mg/dL) and serum creatinine levels (8.9 mg/dL) were highly increased suggesting severe form of disease.\nOn performing ANCA serology, her serum showed a predominantly diffuse, granular cytoplasmic ANCA (c-ANCA) staining pattern on indirect immunofluorescence. By direct enzyme-linked immunosorbent assay, there were high titers of ANCA directed against proteinase-3 (PR-3). PR-3 (1:100 with 1+ intensity) was highly raised and confirmed the diagnosis of granulomatosis with polyangiitis associated with c-ANCA positivity.\nThe patient underwent two sessions of hemodialysis with a 2-day interval with packed red cell transfusion. Following that, serum urea and creatinine levels were controlled. Due to high levels of circulating c-ANCA autoantibodies, TPE was planned in addition to the standard therapy. GPA comes under category I, Grade 1A; American Society for Apheresis guidelines 2016.[] TPE sessions were started on the 4thday of admission. A total of seven cycles was performed with 1.3 total plasma volumes exchanged on every alternate day. Fresh frozen plasma (FFP) and normal saline were used as replacement fluids. During the third cycle of TPE after 5 units of FFP transfusion, the patient developed allergic reaction in the form of severe itching all over the body. To treat allergic reaction, oral pheniramine maleate 5 mg and injection hydrocortisone 100 mg intravenous (i.v.) were given, and after 20 min, procedure was restarted and completed successfully. Rest six cycles of TPE was done uneventfully. Simultaneously, standard induction therapy was also started that comprised of combination of cyclophosphamide (500 mg, i.v.) and methylprednisolone 1000 mg, i.v. daily for 3 days followed by oral prednisolone 60 mg daily for at least 4 weeks. Mesna 200 mg slow i.v. over 2 h was also given to prevent cyclophosphamide-induced hemorrhagic cystitis. Regular monitoring of full blood count, serum proteins, renal function, liver function, urine cytology, and clinical symptoms were done. After seven cycles of TPE, the patient was improved clinically as indicated by her renal function tests and ANCA serology and hence TPE was stopped. The patient's recovery was faster due to the timely intervention of TPE along with standard immunosuppression therapy. The total hospital stay of patient was 18 days which was lesser in comparison to the patient who were treated with standard therapy alone. After that, the patient was on maintenance therapy with azathioprine (2 mg/kg/body weight) at least for 12 months and advised for monthly follow-up.", "Question": "Using the 2021 CKD-EPI Creatinine equation, what is the patient's Glomerular Filtration Rate (GFR) in terms of mL/min/1.73 m\u00b2?", "LLM Answer": "name 'N' is not defined", "LLM Explanation": "name 'N' is not defined", "LLM Thinking": "No Thoughts", "Ground Truth Answer": "5.366", "Ground Truth Explanation": "The formula for computing GFR is 142 x (Scr/A)**B x 0.9938**age x (gender_coeffcient), where the ** indicates an exponent operation, Scr is the concentration of serum creatinine in mg/dL and gender_coefficient is 1.012 if the patient is female, else the coeffient is 1. The coefficients A and B are dependent on the patient's gender and the patient's creatinine concentration.\nThe patient is 38 years old. The patient's gender is Female, and so the patient's gender coefficient is 1.012.\nThe concentration of Serum Creatinine is 8.9 mg/dL. Because the patient's gender is female and the creatinine concentration is greater than or equal to 0.7 mg/dL, A = 0.7 and B = -1.2.\nPlugging in these values, we get 142 * (8.9/0.7)**-1.2 * 0.9938**38 * 1.012 = 5.366.\nHence, the GFR value is 5.366 ml/min/1.73 m\u00b2.", "Result": "Incorrect"}
{"Row Number": 449, "Calculator Name": "FeverPAIN Score for Strep Pharyngitis", "Calculator ID": "33", "Category": "diagnosis", "Note ID": "pmc-8610453-1", "Patient Note": "A 77-year-old male with a past medical history significant for hypertension, stroke, and prostate cancer presented to the emergency department for accidental ingestion with nausea and vomiting. Approximately 90 minutes prior to arrival, the patient had gone to the refrigerator for water and had mistaken a bottle of 35% hydrogen peroxide for water, subsequently ingesting approximately 150 milliliters (mL). The patient immediately felt a burning sensation in his mouth and throat, followed by nausea and vomiting. He reportedly vomited several times, mostly dry heaving, but at one point had a small amount of blood in the vomitus. He otherwise denied any other complaints.\nThe patient was in no acute distress upon arrival. His blood pressure was elevated at 157/84 millimeters of mercury, respiratory rate 20 breaths per minute, pulse 65 beats per minute, and arterial oxygen saturation was 98% on room air. Complete physical examination was negative for posterior oropharyngeal erythema, abdominal tenderness, rebound, or guarding. Laboratory results were significant for an elevated leukocyte count of 18.9 \u00d7 103 thousand per millimeters cubed (K/mm3) (reference range: 4.5\u201311.0 K/mm3), hemoglobin of 16.4 grams per deciliter (g/dL) (12.0\u201316.0 g/dL), creatinine of 1.7 milligrams (mg)/dL (0.5\u20131.4 mg/dL), and lipase of 844 U/L (73\u2013393 U/L). Initial imaging via computed tomography (CT) of the abdomen and pelvis with contrast revealed gastric pneumatosis extending into the distal esophagus with extensive portal venous air, diverticulosis, multiple left renal cysts, and a 5.8-centimeter (cm) adrenal myolipoma ().\nGiven the patient\u2019s presenting symptoms combined with the CT findings of gastric pneumatosis, the poison center and gastroenterology were consulted. The patient was admitted for observation with plans for an endoscopy; however, upon surgical consultation, he was emergently transferred to a tertiary care hospital due to concerns for a potential perforation and necrosis of the gastric body and distal esophagus, which may have necessitated a total gastrectomy as well as distal esophagectomy. The patient had been placed on a nothing-by-mouth restriction on admission and was hemodynamically stable on intravenous (IV) fluids, pantoprazole IV drip, and piperacillin-tazobactam at time of transfer.\nUpon arrival at the tertiary center, the patient reported overall improvement of his abdominal pain and sore mouth. Esophagogastroduodenoscopy performed there confirmed moderate to severe distal esophagitis and severe pangastritis but no evidence of necrosis, linear ulcerations along the lesser curvature, or mild bulbar duodenitis. Gastric biopsy later demonstrated fundic type gastric mucosa with acute inflammation and epithelial erosion. Following his endoscopy, the patient tolerated clear liquids and had his diet advanced to surgical soft. He remained pain-free and was deemed stable for discharge on the third day with recommendations for a repeat endoscopy in two to three months.", "Question": "What is the patient's FeverPAIN score?", "LLM Answer": "1", "LLM Explanation": "The FeverPAIN score assesses Clostridium difficile infection severity with components: Fever (\u226538.3\u00b0C), Leukocytosis (WBC \u226515,000/mm\u00b3), Abdominal pain/tenderness, INR \u22651.2, Altered mental status, and Hypotension (SBP <90 or DBP <60). \\n\\n1. **Fever**: No temperature provided; not met.\\n2. **Leukocytosis**: WBC 18.9 K/mm\u00b3 (\u226515,000) \u2192 **met**.\\n3. **Abdominal pain/tenderness**: Denied abdominal pain initially; physical exam negative for tenderness \u2192 **not met**.\\n4. **INR elevation**: Not mentioned \u2192 **not met**.\\n5. **Altered mental status**: Patient in no acute distress \u2192 **not met**.\\n6. **Hypotension**: BP 157/84 \u2192 **not met**.\\n\\nTotal score: 1 (only leukocytosis met).", "LLM Thinking": " <think> Okay, let's tackle this question. The user is asking for the patient's FeverPAIN score. First, I need to recall what the FeverPAIN score is. From what I remember, FeverPAIN is a scoring system used to assess the severity of Clostridium difficile infection (CDI) in patients. The components of the score are: - Fever (temperature \u226538.3\u00b0C) - Leukocytosis (white blood cell count \u226515,000/mm\u00b3) - Abdominal pain or tenderness - INR elevation (\u22651.2) - Altered mental status - Hypotension (systolic BP <90 mmHg or diastolic BP <60 mmHg) Each component present is worth 1 point, so the total score ranges from 0 to 6. Higher scores indicate more severe disease. Now, I need to go through the patient note and check each component of the FeverPAIN score to see which ones apply. Starting with Fever: The note mentions the patient's temperature isn't directly stated. The vital signs listed are blood pressure 157/84, respiratory rate 20, pulse 65, and oxygen saturation 98%. There's no mention of a fever or temperature reading. So probably this component isn't met. Next, Leukocytosis: The lab results show a leukocyte count of 18.9 \u00d710\u00b3 K/mm\u00b3. The reference range is 4.5\u201311.0, so 18.9 is definitely above 15,000. That's a yes for leukocytosis. Abdominal pain or tenderness: The patient presented with nausea and vomiting, but the physical exam didn't show abdominal tenderness, rebound, or guarding. The patient denied other complaints initially. However, later when transferred, he reported improvement in abdominal pain. Wait, the initial presentation mentions nausea and vomiting, but the physical exam was negative for tenderness. The question is whether \"abdominal pain\" is present. The patient had some improvement, but at the time of admission, did he have abdominal pain? The note says \"otherwise denied any other complaints\" besides nausea, vomiting, and blood in vomitus. So maybe he didn't have abdominal pain. The tertiary center noted he had improvement in abdominal pain, implying he had some before. But the FeverPAIN score is based on presentation at the time of assessment. Since the score is for CDI severity, but the patient here had hydrogen peroxide ingestion, not CDI. Wait, hold on. Wait, the FeverPAIN score is for C. diff, but the patient's issue is from hydrogen peroxide ingestion. Is the question still applicable here? The user is asking for the FeverPAIN score regardless of the underlying condition? Maybe the question is a trick, but perhaps the user expects us to apply it even if it's not C. diff. Let me proceed. Assuming we proceed, the patient's initial presentation didn't mention abdominal pain, but later he had some improvement, so maybe he did have abdominal pain at some point. The physical exam didn't show tenderness, but the presence of pain might still count. The note says \"denied any other complaints\" besides the mentioned symptoms. Hmm, maybe he didn't have abdominal pain. This is a bit ambiguous. Let me check again. The initial presentation says \"presented with accidental ingestion with nausea and vomiting.\" The rest of the complaints are nausea, vomiting, and blood in vomitus. The physical exam didn't show abdominal tenderness. So maybe abdominal pain isn't present. So this component might not be met. INR elevation: The lab results don't mention INR. The labs listed are WBC, hemoglobin, creatinine, and lipase. No INR value given. So this component is not met. Altered mental status: The patient was in no acute distress, and there's no mention of altered mental status. So no. Hypotension: The blood pressure was 157/84, which is elevated systolic but not hypotensive. Hypotension in FeverPAIN is systolic <90 or diastolic <60. So no. So tallying up: Leukocytosis (1 point). The others are not met. So the FeverPAIN score would be 1. Wait, but let me double-check each component again. Wait, the abdominal pain component: The patient had nausea and vomiting, but does that count as abdominal pain? The FeverPAIN criteria specifically mention abdominal pain or tenderness. The patient's symptoms are nausea and vomiting, which are gastrointestinal but not necessarily abdominal pain. The physical exam didn't show tenderness. So probably not. So only leukocytosis is present. So the score is 1. Wait, but the patient was transferred to a tertiary center due to concerns for perforation and necrosis, and later endoscopy showed esophagitis and gastritis. But the FeverPAIN score is for C. diff, so maybe this is a distractor. The question might be testing if I know that the FeverPAIN is for C. diff, but the patient here has a different condition. However, the user is asking for the FeverPAIN score regardless. Alternatively, maybe the question is a trick, and the answer is that the FeverPAIN score isn't applicable here because it's not C. diff. But the user might expect us to calculate it based on the given data even if it's not the right context. Since the task is to compute the score, I'll proceed with the components as per the data. So, components met: Leukocytosis (1). Total score 1. But wait, let me check again. The patient's WBC is 18.9, which is over 15, so yes. The other components: no fever, no abdominal pain (as per the initial presentation), no INR, no altered mental status, no hypotension. So the FeverPAIN score is 1. Wait, but the patient's lipase is elevated (844 U/L), which is above the upper limit of 393. Does that relate to any component? No, FeverPAIN doesn't include lipase. The components are the ones listed. So the answer should be 1. Alternatively, maybe I missed something. Let me check again. The patient had gastric pneumatosis and portal venous air, which are serious, but those are part of the injury from hydrogen peroxide, not C. diff. The FeverPAIN score is for C. diff, so maybe the correct answer is that it's not applicable. But the question is asking for the score regardless. Hmm. The user might expect the calculation based on the given data even if the context isn't C. diff. So I think the answer is 1. ", "Ground Truth Answer": "1", "Ground Truth Explanation": "The patient's current FeverPain score is 0.\nWhether the patient has a fever in the past 24 hours is not reported and so we assume that it is absent for the patient. Because of this, we do not increment the score, keeping the current total at 0.\n'The patient is reported to have an absence of cough or coryza and so we increment the score by 1, making the current total 0 + 1 = 1.\nWhether the patient has a symptom onset \u22643 days is not reported and so we assume that it is absent for the patient. Because of this, we do not increment the score, keeping the current total at 1.\nThe patient is reported to not have purulent tonsils and so we do not increment the score, keeping the current total at 1.\nThe patient is reported to not have severe tonsil inflammation and so we do not increment the score, keeping the current total at 1.\nThe patient's FeverPain score is 1 points.", "Result": "Correct"}
{"Row Number": 199, "Calculator Name": "QTc Bazett Calculator", "Calculator ID": "11", "Category": "physical", "Note ID": "20", "Patient Note": "Patient has a heart rate of 46 bpm and a QT interval of 330 msec.", "Question": "Using the Bazett Formula for corrected QT interval, what is the patient's corrected QT interval in msec?", "LLM Answer": "289", "LLM Explanation": "1. The Bazett formula is QTc = QT / \u221a(RR interval in seconds). \\n2. Calculate RR interval: 60 seconds/minute \u00f7 46 bpm \u2248 1.3043 seconds. \\n3. Compute square root of RR: \u221a1.3043 \u2248 1.142. \\n4. Divide QT by \u221aRR: 330 msec \u00f7 1.142 \u2248 289 msec.", "LLM Thinking": " <think> Okay, let's see. The patient's heart rate is 46 bpm and their QT interval is 330 msec. The task is to use the Bazett Formula to find the corrected QT interval. Hmm, I remember the Bazett formula is used to adjust the QT interval for heart rate. The formula is something like QTc = QT divided by the square root of the RR interval. Wait, but how do I get the RR interval from the heart rate? Right, the RR interval is the time between heartbeats. Since the heart rate is beats per minute, the RR interval in seconds would be 60 divided by the heart rate. Let me check that. So if the heart rate is 46 bpm, then the RR interval is 60/46. Let me calculate that: 60 divided by 46 is approximately 1.3043 seconds. Wait, but when using the Bazett formula, the units might need to be in terms of the R-R interval in seconds. So first, compute RR interval: 60 / 46 \u2248 1.3043 seconds. Then the square root of that is sqrt(1.3043). Let me calculate that. The square root of 1.3043 is approximately 1.142. Now, the original QT is 330 msec. So the corrected QT interval (QTc) would be 330 divided by 1.142. Let me do that division. 330 / 1.142 \u2248 288.99, which rounds to about 289 msec. Wait, but I should check if the formula uses the square root of the RR interval in seconds. Let me confirm the formula again. Yes, Bazett's formula is QTc = QT / sqrt(RR), where RR is in seconds. So the steps are: 1. Calculate RR interval: 60 / HR = 60/46 \u22481.3043 sec. 2. Take the square root of RR: sqrt(1.3043) \u22481.142. 3. Divide QT by that value: 330 /1.142 \u2248289 msec. Therefore, the corrected QT interval is approximately 289 msec. Wait, but sometimes people might round differently. Let me double-check the calculations. 60 divided by 46 is exactly 1.304347826. Square root of that is sqrt(1.304347826) \u22481.142. 330 divided by 1.142 is indeed around 288.99, so 289.0. Yeah, that seems right. So the answer should be 289 msec. ", "Ground Truth Answer": "288.985", "Ground Truth Explanation": "The corrected QT interval using the Bazett formula is computed as  QTc = QT interval / \u221a (RR interval), where the QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 46 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/46 = 1.304.\nHence, plugging in these values, we will get 330/\u221a(1.304) = 288.985.\nThe patient's corrected QT interval (QTc) is 288.985 msec. ", "Result": "Correct"}
{"Row Number": 425, "Calculator Name": "HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)", "Calculator ID": "31", "Category": "lab", "Note ID": "pmc-4864000-2", "Patient Note": "A 14 year old Hispanic female with a 3 year history of type 2 diabetes on once-daily DPP-4 inhibitor Sitagliptin presented for evaluation of morbid obesity with asthma, obstructive sleep apnea, reflux, and irregular menses. She was overweight since preschool age. Family history was notable for type 2 diabetes, obesity, hypertension, hyperlipidemia, and cholelithiasis.\nAt initial preoperative evaluation for bariatric surgery, weight was 129.3kg, height was 154.5cm, and BMI was 54.2kg/m2. Laboratory values were consistent with type 2 diabetes with HbA1c 10.7%, FG 210mg/dL, and 2 hour glucose 378mg/dL, and metabolic syndrome with TG 138mg/dL, HDL 39mg/dL, WC 142cm and elevated BP 120/83 (96th percentile diastolic). Despite Sitagliptin100mg daily, Lantus 28 units daily and Metformin XR 1000mg, HbA1c remained between 9.9% and 10.3% for 6 months. She refused further increase in Metformin dose given gastrointestinal complaints. Sitagliptin was stopped and Exenatide 2mg QW was initiated as adjuvant treatment to Lantus 28 units and Metformin 1000mg daily at weight 131.1kg, BMI 54.4kg/m2, HbA1c 10.2%, and FG 163mg/dl. Within two months of treatment, HbA1c improved to 7.9%. After 6 months, she had sustained glycemic control with HbA1c 8.3% and notable improvements in cardiometabolic parameters including FG (\u221217mg/dl), insulin (\u221226uIU/ml), and TG (\u221212mg/dl). Patient\u2019s weight was 131.5kg on day of gastric sleeve resection surgery with Exenatide QW discontinued following surgery due to normalization of blood glucose levels (HbA1c 5.8%) and weight 118.9kg noted at 2 months postoperatively.", "Question": "What is the patient's HOMA-IR score?", "LLM Answer": "name 'N' is not defined", "LLM Explanation": "name 'N' is not defined", "LLM Thinking": " <think> Okay, let's see. The user is asking for the patient's HOMA-IR score. HOMA-IR stands for Homeostatic Model Assessment for Insulin Resistance. To calculate that, I need two values: fasting glucose (FG) and fasting insulin. The formula is HOMA-IR = (FG \u00d7 insulin) / 22.5. Looking at the patient note, I need to find the fasting glucose and fasting insulin levels. The note mentions several lab values. Let me go through the details again. The initial labs at preoperative evaluation show a fasting glucose (FG) of 210 mg/dL. But later, after starting Exenatide, her FG improved. Specifically, after two months, HbA1c was 7.9%, and at six months, FG was 163 mg/dL. Wait, but the question is about HOMA-IR. Do they provide fasting insulin anywhere? Looking again, under the 6-month mark, it says \"insulin (\u221226uIU/ml)\". Hmm, that might be a change from baseline. Wait, the note says \"insulin (\u221226uIU/ml)\" which could mean a decrease of 26 units per microliter from a previous value. But without the baseline insulin level, I can't calculate the exact value. Wait, maybe I missed the initial insulin level. Let me check again. The initial labs mention HbA1c, FG, 2-hour glucose, TG, HDL, WC, and BP. But insulin isn't listed there. Then, when they stopped Sitagliptin and started Exenatide, the HbA1c was 10.2% and FG 163. Then after two months, HbA1c improved to 7.9%. At six months, the FG is 163 again? Wait, no, the six-month part says \"FG (\u221217mg/dl)\", which might mean a decrease of 17 from a previous value. Wait, the wording is a bit confusing. Let me parse that again. The note says: \"After 6 months, she had sustained glycemic control with HbA1c 8.3% and notable improvements in cardiometabolic parameters including FG (\u221217mg/dl), insulin (\u221226uIU/ml), and TG (\u221212mg/dl).\" So the FG decreased by 17 mg/dL from some baseline. But what was the baseline? Maybe the initial FG was 210, then after treatment, it went down. Wait, when they started Exenatide, her FG was 163 (since at the time of starting Exenatide, her FG was 163). Then after two months, HbA1c improved to 7.9%, but FG isn't specified there. At six months, the FG is 163 minus 17, so 146? But I'm not sure. Alternatively, maybe the FG at six months is 163 minus 17, so 146? But without knowing the exact FG at the time of the HOMA-IR calculation, this is tricky. Wait, the question is asking for the HOMA-IR score. The problem is that the note doesn't explicitly state the fasting insulin level at any point. The only insulin value mentioned is a decrease of 26 uIU/mL after six months. Without knowing the baseline insulin, we can't compute the actual value. For example, if the initial insulin was X, then after six months it's X-26. But without X, we can't know. Alternatively, maybe the HOMA-IR is calculated at a specific time point mentioned. Let me check again. The note mentions that after six months, the insulin decreased by 26. But without the actual insulin level, perhaps the question expects using the data available. Wait, maybe I missed an insulin value. Let me re-read the entire note carefully. The initial labs: \"Laboratory values were consistent with type 2 diabetes with HbA1c 10.7%, FG 210mg/dL, and 2 hour glucose 378mg/dL, and metabolic syndrome with TG 138mg/dL, HDL 39mg/dL, WC 142cm and elevated BP 120/83 (96th percentile diastolic).\" So no insulin here. Then, when they started Exenatide, the HbA1c was 10.2%, FG 163. Then after two months, HbA1c 7.9%. At six months, FG decreased by 17 (so FG would be 163-17=146?), and insulin decreased by 26. But again, without the actual insulin value, we can't compute HOMA-IR. Wait, maybe the question is expecting us to use the data at a certain point where insulin is mentioned. The only insulin data is the decrease of 26. Since the problem is presented in a clinical context, perhaps the HOMA-IR is calculated at the time when the insulin level was measured. But since the note doesn't provide the actual insulin level, only the change, it's impossible to calculate. Hmm, maybe I made a mistake. Let me check again. The note says \"insulin (\u221226uIU/ml)\" after six months. The parentheses might indicate the change from baseline. So if the baseline insulin was, say, X, then after six months it's X-26. But without X, we can't compute. Alternatively, maybe the HOMA-IR is calculated using the change? That doesn't make sense. Alternatively, perhaps the question expects using the data at the time of starting Exenatide. At that point, her HbA1c was 10.2%, FG 163, but again, no insulin. Wait, maybe the HOMA-IR is calculated post-surgery? The note says after surgery, Exenatide was discontinued because HbA1c normalized to 5.8% and weight was 118.9kg. But again, no insulin value there. Hmm, this is confusing. The problem might be that the necessary data isn't present in the note. But since the user is asking for the HOMA-IR, maybe I missed an insulin value. Let me check again. Wait, the note says \"insulin (\u221226uIU/ml)\" after six months. The minus sign might indicate a decrease from baseline. So if the initial insulin level was, say, 26 uIU/mL, then after six months it's 0? That can't be. Alternatively, maybe the baseline insulin was higher. For example, if the initial insulin was 50, then after six months it's 24. But without knowing the baseline, we can't compute. Alternatively, maybe the HOMA-IR is calculated using the FG and insulin at the time when the HbA1c was 8.3% at six months. But without the actual insulin value, only the change, it's impossible. Wait, perhaps the question is a trick question where the data isn't provided, so the answer is \"Insufficient data to calculate HOMA-IR\". But maybe I missed something. Let me check again. Wait, the initial labs: \"Laboratory values were consistent with type 2 diabetes with HbA1c 10.7%, FG 210mg/dL, and 2 hour glucose 378mg/dL, and metabolic syndrome with TG 138mg/dL, HDL 39mg/dL, WC 142cm and elevated BP 120/83 (96th percentile diastolic).\" So no insulin here. When they started Exenatide, the HbA1c was 10.2%, FG 163. Still no insulin. After six months, the insulin decreased by 26. So if the initial insulin was, say, at the time of starting Exenatide, maybe they measured it then? The note doesn't say. Alternatively, maybe the HOMA-IR is calculated using the FG at six months (146 mg/dL, assuming the decrease from 163) and the insulin level of (X-26). But without X, can't compute. Hmm, perhaps the question expects using the data at the time of the preoperative evaluation, but that's before starting Exenatide. At that time, FG was 210, but no insulin. Alternatively, maybe the HOMA-IR is calculated post-surgery when HbA1c was 5.8%, but again, no insulin. Wait, maybe the question is expecting an approximate calculation using the available data, even if it's not perfect. For example, maybe using the FG at six months (assuming FG is 163-17=146) and the insulin decrease of 26. But without the baseline, this is impossible. Alternatively, perhaps the HOMA-IR is calculated at the time when Exenatide was started. At that point, FG was 163, but insulin isn't given. Hmm, I'm stuck. The problem might be that the necessary data isn't present in the note. Therefore, the answer would be that there's insufficient information to calculate HOMA-IR. But maybe I missed an insulin value. Let me check once more. Wait, the note says \"insulin (\u221226uIU/ml)\" after six months. The parentheses might indicate the change from baseline. If the baseline insulin was, say, at the time of starting Exenatide (when HbA1c was 10.2% and FG 163), perhaps they measured insulin then. But the note doesn't state that. Alternatively, maybe the HOMA-IR is calculated using the FG at the time of surgery. The surgery was at 131.5kg, and Exenatide was discontinued then because HbA1c normalized. But again, no insulin value. Hmm, I think the answer is that there's insufficient data to calculate HOMA-IR because the fasting insulin level isn't provided anywhere in the note. The only insulin data is a decrease from baseline, but without the baseline value, we can't compute the actual HOMA-IR. Wait, but maybe the question expects using the data at the time when the HbA1c was 8.3% at six months. The FG decreased by 17 from a previous value. If the previous FG was 163 (when Exenatide was started), then 163-17=146. The insulin decreased by 26 from baseline. If the baseline insulin was, say, at the time of starting Exenatide, but that's not given. Alternatively, maybe the HOMA-IR is calculated using the initial FG of 210 and assuming an insulin level. But that's just a guess. Alternatively, perhaps the question is a trick, and the answer is that the data isn't available. Hmm, I think the correct answer here is that there's insufficient information to calculate HOMA-IR because fasting insulin isn't provided anywhere in the note. The only insulin data is a change from baseline, which isn't enough. ", "Ground Truth Answer": "13.481", "Ground Truth Explanation": "The formula for computing HOMA-IR score is (insulin (\u00b5IU/mL) * glucose mg/dL)/405.\nThe concentration of insulin is 26.0 \u00b5IU/mL.\nThe concentration of glucose is 210.0 mg/dL. \nPlugging into the formula will give us 26.0 * 210.0/405 = 13.481. Hence, the patient's HOMA-IR score is 13.481. ", "Result": "Incorrect"}
